2020 $200k Challenge Finalist: CranioSense
Come Join Vivonics’ subsidiary, CranioSense, as Gordon Hirschman CEO & Founder presents at the 2020 $200K Challenge. This year’s challenge will take place virtually over Zoom on September 17th from 5-8PM.
(IPASS)- Intracranial Pressure and Assessment Screening System
IPASS is a noninvasive device for continuous assessment of intracranial pressure (ICP). ICP increases after a traumatic brain injury due to a blow to the head or because of other medical conditions that impact the brain. In current practice, ICP is only continuously monitored by invasive devices requiring surgical installation. Vivonics’ subsidiary CranioSense is currently developing IPASS to provide a low-cost solution to assess ICP quickly and easily and continue to monitor for changes, allowing the physician to determine appropriate patient care.
